Noliprel Arg pharmaceutical

Noliprel Arg (also known as Noliprel Arginine) is a prescription pharmaceutical product used primarily for the treatment of essential hypertension. It is a combination medication containing perindopril arginine and indapamide. The brand is a core product of the French pharmaceutical group Servier, which pioneered the development of perindopril-based treatments in the cardiovascular field.

The medication is manufactured across several European facilities to ensure global supply, with significant production centers located in Gidy, France, as well as Arklow, Ireland, and Anielin, Poland. Servier maintains a robust supply chain within the European Union, adhering to strict pharmaceutical manufacturing standards.

Servier is a unique entity in its industry, as it is governed by a non-profit foundation, the F.R.I.S. (Foundation de Recherche Internationale Servier). This structure allows the company to focus long-term on research and development without the pressures of publicly traded stock markets. Based in Suresnes, France, the ultimate ownership reflects its origins as an independent, private French enterprise.